Scientific review finds aspirin significantly cuts cancer rates
Published on Aug 6, 2014 7:19 AM
LONDON (REUTERS) - Taking a small daily dose of aspirin can significantly reduce the risk of developing - or dying from - bowel, stomach and oesophageal cancer, according to a large review of scientific studies.
Researchers who analysed all available evidence from studies and clinical trials assessing benefits and harm found that taking aspirin for 10 years could cut bowel cancer cases by around 35 per cent and deaths from the disease by 40 per cent.
Rates of oesophageal and stomach cancer were cut by 30 per cent and deaths from these cancers by 35 to 50 per cent.
Professor Jack Cuzick, head of the centre for cancer prevention at Queen Mary University of London, said the evidence showed that, to reap the benefits of aspirin, people need to take a daily dose of 75 to 100 milligrams for at least five years and probably up to 10 years between the ages of 50 and 65.
To continue reading, log in if you are a subscriber
If you are not a subscriber, you can get instant, unlimited access here